Seoul, Korea, August 13, 2024 – Roquette, a global leader in plant-based ingredients and a leading provider of pharmaceutical excipients, is proud to announce that it has been awarded the prestigious “Biopharma Innovation of the Year” Award at the Korea Biopharma Excellence Awards 2024.
Roquette was recognized for its outstanding contributions to biopharma innovation, particularly for its advancements in developing cutting-edge excipients that enhance the delivery and efficacy of biologic drugs. This award highlights Roquette’s commitment to pushing the boundaries of what is possible in biopharmaceutical development, ultimately benefiting patients worldwide.
Sponsored by IMAPAC, the Korea Biopharma Excellence Awards celebrate the achievements of companies and individuals who have made significant contributions to the biopharma industry in Korea and beyond. The awards recognize leaders in biologics, cell and gene therapy, and vaccine development, and inspire future innovators to continue advancing the field. Learn more about the awards here.
Vinod Tuliani, PhD, Vice President and Head of Global Pharmaceutical Sciences at Roquette, expressed his appreciation for the award, stating: “Receiving this prestigious accolade is a significant honor for Roquette. It emphasizes our unwavering commitment to advancing pharmaceutical innovation and highlights the success of our KLEPTOSE® Biopharma solution. This recognition reflects the expertise and dedication of our team and reinforces our drive to continue developing solutions that address the evolving challenges of the biopharma industry.”
KLEPTOSE® Biopharma hydroxypropyl beta-cyclodextrin is designed to meet the stringent demands of pharmaceutical development, offering a high-purity, reliable solution for enhancing the solubility and stability of active pharmaceutical ingredients (APIs). This excipient is highly valued for its ability to improve bioavailability, reduce subvisible particle formation, and prevent API degradation. With a strong safety profile and consistent performance, KLEPTOSE® Biopharma plays a critical role in optimizing the formulation of complex biologics, ensuring that pharmaceutical products maintain their efficacy and quality throughout their life cycle. As a trusted partner in pharmaceutical innovation, Roquette continues to support the advancement of next-generation therapies with KLEPTOSE® Biopharma, helping manufacturers achieve superior outcomes in drug development.
The recognition of Roquette with the Biopharma Innovation of the Year Award underscores the company’s dedication to innovation and excellence, reinforcing its position as a key player in the global biopharma industry.
For more information about Roquette KLEPTOSE® Biopharma, visit this link.
ABOUT IMAPAC
IMAPAC is a leading event management company specializing in the biopharmaceutical industry. With over 12 years of experience, IMAPAC has successfully organized more than 50 industry events, attracting over 15,000 participants from around the world. IMAPAC’s events are renowned for their high-quality content, prestigious speakers, and networking opportunities.
ABOUT ROQUETTE: “OFFERING THE BEST OF NATURE”
Roquette is a family-owned global leader in plant-based ingredients and a leading provider of pharmaceutical excipients. Founded in 1933, the company currently operates in more than 100 countries, through more than 30 manufacturing sites, has a turnover of around 5 billion euros, and employs almost 10,000 people worldwide.
Life and nature have been our sources of inspiration for decades. All our raw materials are of natural origin. From them, we enable a whole new plant-based cuisine; we offer pharmaceutical solutions that play a key role in medical treatments; and we develop innovative ingredients for food, nutrition and health markets. We truly unlock the potential of nature to improve, cure and save lives.
Thanks to a constant drive for innovation and a long-term vision, we are committed to improving the well-being of people all over the world. We put sustainable development at the heart of our concerns, while taking care of resources and territories. We are determined to create a better and healthier future for all generations. Discover more about Roquette on this link.
For further details, contact:
Cookie Lo
Head of Communications & Public Affairs – Greater Asia Roquette
[email protected]
